FDA orders safety studies for some asthma drugs
Reuters WASHINGTON (Reuters) – Health regulators have ordered drugmakers to conduct clinical trials involving a total of 53000 patients to test the safety of a controversial class of inhaled asthma drugs that are already on the market. … FDA Drug Safety Communication: FDA requires post-market safety trials for Long … |
View full post on asthma – Google News